Sanofi invests in China startup GluBio in developing molecular glue for sickle cell

A small startup based in San Diego and Shanghai believes it has figured out how to boost hemoglobin levels with a pill, potentially offering a cheaper and simpler alternative to expensive and onerous gene editing …
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks


ADVERTISEMENT — Advertise With Biotech Networks